NEONC TECHNOLOGIES HOLDINGS, INC. Finance Lease, Right-of-Use Asset, Amortization
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Finance Lease, Right-of-Use Asset, Amortization of $39.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $18.59K.
- NEONC TECHNOLOGIES HOLDINGS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $20.41K.
- NEONC TECHNOLOGIES HOLDINGS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $18.31K, a 72.71% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $36.46K, a 85.18% decline from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $245.94K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $39.00K 10-Q · filed 2026-08-10 | $39.00K derived: sum of 3 quarters · filed 2026-08-10 | $57.30K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $20.41K 10-Q · filed 2026-05-15 | $20.41K derived: sum of 2 quarters · filed 2026-05-15 | $38.71K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $18.31K derived: sum of 2 quarters · filed 2026-03-31 | $36.46K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $18.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $36.46K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | $18.15K 10-Q · filed 2026-08-10 | |||
| 2024-12-31 | $67.08K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $134.15K derived: sum of 2 quarters · filed 2026-03-31 | $245.94K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $67.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $178.87K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $111.79K 10-Q · filed 2025-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |